14-Aug-2026
UBS Releases a Hold Rating on Aveanna Healthcare Holdings (AVAH)
TipRanks (Fri, 14-Aug 8:55 AM ET)
Aveanna Healthcare Holdings (AVAH) Receives a Buy from Deutsche Bank
TipRanks (Fri, 14-Aug 8:45 AM ET)
TipRanks (Fri, 14-Aug 7:30 AM ET)
TipRanks (Fri, 14-Aug 7:20 AM ET)
Barclays Keeps Their Buy Rating on Aveanna Healthcare Holdings (AVAH)
TipRanks (Fri, 14-Aug 4:36 AM ET)
Aveanna hits 52-week high after Q2 beat, guidance hike
Seeking Alpha News (Fri, 14-Aug 1:48 AM ET)
Aveanna Healthcare Raises 2026 Revenue Outlook After Double-Digit Q2 Growth
Market Chameleon (Thu, 13-Aug 7:15 AM ET)
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks (Thu, 13-Aug 10:50 AM ET)
Aveanna Healthcare Raises 2026 Outlook After Strong Quarter
TipRanks (Thu, 13-Aug 7:36 AM ET)
Aveanna Highlights Growth and Scale in Investor Presentation
TipRanks (Thu, 13-Aug 7:36 AM ET)
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.
Aveanna Healthcare Hldgs trades on the NASDAQ stock market under the symbol AVAH.
As of August 14, 2026, AVAH stock price climbed to $12.32 with 6,748,472 million shares trading.
AVAH has a beta of 1.95, meaning it tends to be more sensitive to market movements. AVAH has a correlation of 0.10 to the broad based SPY ETF.
AVAH has a market cap of $2.69 billion. This is considered a Mid Cap stock.
Last quarter Aveanna Healthcare Hldgs reported $670 million in Revenue and $.22 earnings per share. This beat revenue expectation by $30 million and exceeded earnings estimates by $.05.
In the last 3 years, AVAH traded as high as $12.52 and as low as $.85.
The top ETF exchange traded funds that AVAH belongs to (by Net Assets): VTI, FESM, IWM, FYC, VXF.
AVAH has outperformed the market in the last year with a price return of +71.1% while the SPY ETF gained +21.5%. AVAH has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +65.6% and +31.2%, respectively, while the SPY returned +4.0% and +3.9%, respectively.
AVAH support price is $10.97 and resistance is $11.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVAH shares will trade within this expected range on the day.